Clinical trial
Anterior Cruciate Ligament (ACL) Reconstruction with a New Generation of LARS Artificial Ligament
NCT06571955 is registered in ClinicalTrials.gov with MOVMEDIX as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anterior Cruciate Ligament (ACL) Reconstruction with a New Generation of LARS Artificial Ligament
- Lead sponsor
- MOVMEDIX
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 22, 2021
- Completion date
- December 31, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl injury